HCA Healthcare (NYSE:HCA) Given New $431.00 Price Target at TD Cowen

HCA Healthcare (NYSE:HCA) had its price target lowered by analysts at TD Cowen from $500.00 to $431.00 in a research note issued on Monday,MarketScreener reports. The firm currently has a “buy” rating on the stock. TD Cowen’s price objective would indicate a potential upside of 15.18% from the stock’s current price.

A number of other equities analysts have also recently commented on HCA. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Robert W. Baird dropped their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a report on Thursday, June 4th. Barclays cut their price objective on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Finally, Stephens dropped their price target on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $503.00.

HCA Healthcare Stock Performance

NYSE:HCA opened at $374.19 on Monday. HCA Healthcare has a 52 week low of $330.00 and a 52 week high of $556.52. The firm has a 50-day moving average price of $419.68 and a two-hundred day moving average price of $468.81. The firm has a market cap of $83.01 billion, a price-to-earnings ratio of 12.88, a price-to-earnings-growth ratio of 1.19 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare will post 30.07 earnings per share for the current year.

Institutional Investors Weigh In On HCA Healthcare

Several hedge funds have recently bought and sold shares of HCA. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at $29,000. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter worth about $26,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare in the 4th quarter worth about $31,000. Cedar Mountain Advisors LLC acquired a new stake in HCA Healthcare in the first quarter valued at approximately $33,000. Finally, MCF Advisors LLC raised its stake in shares of HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after buying an additional 49 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.